AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29869601 — intervention group
Group type: EXPERIMENTAL
Intervention: CSP antigen
Number of subjects: 9000
Study 26584869 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (two levels of exercise intensity) for six months
Number of subjects: 52
Study 24526178 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant CMF
Number of subjects: 24
Study 22325113 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (DOX) 100 mg twice daily for 5 days
Number of subjects: 68
Study 22325113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 20186622 — intervention group
Group type: EXPERIMENTAL
Intervention: D(2)/D(3) plus paraaortic lymphadenectomy
Number of subjects: 1446
Study 20186622 — intervention group
Group type: COMPARATOR
Intervention: D(2)/D(3)
Number of subjects: 1446
Study 17402927 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-enhanced approach for teaching psychomotor skills
Number of subjects: 0
Study 17402927 — intervention group
Group type: COMPARATOR
Intervention: Traditional skills laboratory format (control group)
Number of subjects: 0
Study 16119484 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS-guided anaesthesia
Number of subjects: 2463
Study 16119484 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 2463
Study 12098169 — intervention group
Group type: EXPERIMENTAL
Intervention: RN/MD patient care team (operational change)
Number of subjects: 962
Study 9916664 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate mouth washing (n = 18)
Number of subjects: 28
Study 9916664 — intervention group
Group type: COMPARATOR
Intervention: Placebo washing (n = 10)
Number of subjects: 28
Study 9916664 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate mouth washing
Number of subjects: 28
Study 8781634 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg om for 2-4 weeks followed by maintenance omeprazole 20 mg om for one year
Number of subjects: 20
Study 8781634 — intervention group
Group type: COMPARATOR
Intervention: Short course therapy with omeprazole only, followed by placebo
Number of subjects: 20
Study 2187071 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/day of zidovudine for 18 weeks
Number of subjects: 74
Study 2187071 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 mg/day of zidovudine
Number of subjects: 74
Study 2187071 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,200 mg/day of zidovudine
Number of subjects: 74
Study 2187071 — intervention group
Group type: EXPERIMENTAL
Intervention: Washout phase
Number of subjects: 74
Study 6350474 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir cream
Number of subjects: 0
Study 6350474 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30606815 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (2 mg bolus + 0.5-1 mg/h) + 80% hepatectomy
Number of subjects: 8
Study 30606815 — intervention group
Group type: EXPERIMENTAL
Intervention: Portacaval shunt (PCS) + 80% hepatectomy
Number of subjects: 8
Study 30606815 — intervention group
Group type: COMPARATOR
Intervention: Control (80% hepatectomy alone)
Number of subjects: 8
Study 30359248 — intervention group
Group type: EXPERIMENTAL
Intervention: PNP program (collaborative care program)
Number of subjects: 0
Study 30359248 — intervention group
Group type: COMPARATOR
Intervention: General practitioner program
Number of subjects: 0
Study 30359248 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 27321272 — intervention group
Group type: EXPERIMENTAL
Intervention: Planned vaginal delivery
Number of subjects: 91
Study 27321272 — intervention group
Group type: COMPARATOR
Intervention: Planned cesarean delivery
Number of subjects: 91
Study 24513242 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetric tethering pattern
Number of subjects: 62
Study 24513242 — intervention group
Group type: COMPARATOR
Intervention: Symmetric tethering pattern
Number of subjects: 62
Study 23339378 — intervention group
Group type: COMPARATOR
Intervention: Socket allograft alone
Number of subjects: 24
Study 23339378 — intervention group
Group type: EXPERIMENTAL
Intervention: Socket allograft plus facial overlay xenograft
Number of subjects: 24
Study 20005673 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%
Number of subjects: 0
Study 20005673 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 1%
Number of subjects: 0
Study 20005673 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 10(-4)M
Number of subjects: 0
Study 20005673 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5%, 0.75%, 1%
Number of subjects: 0
Study 18788033 — intervention group
Group type: EXPERIMENTAL
Intervention: Unipolar RF treatment
Number of subjects: 10
Study 16172824 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based swallowing safety training module
Number of subjects: 0
Study 16172824 — intervention group
Group type: COMPARATOR
Intervention: No training (Control group)
Number of subjects: 0
Study 12855342 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (275.5 mg/day average after dose adaptation)
Number of subjects: 127
Study 12855342 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 127
Study 12855342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 10475311 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine for preemptive analgesia in limb surgery
Number of subjects: 0
Study 10475311 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine for preemptive analgesia in mastectomy
Number of subjects: 0
Study 10475311 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine for preemptive analgesia in gastrectomy
Number of subjects: 0
Study 10475311 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine for preemptive analgesia in hysterectomy
Number of subjects: 0
Study 10475311 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine for preemptive analgesia in herniorrhaphy
Number of subjects: 0
Study 10475311 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine for preemptive analgesia in appendectomy
Number of subjects: 0
Study 10475311 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine for preemptive analgesia in hemiorrhaphy
Number of subjects: 0
Study 8595171 — intervention group
Group type: EXPERIMENTAL
Intervention: Fadrozole hydrochloride 0.5 mg orally b.d.
Number of subjects: 80
Study 8595171 — intervention group
Group type: EXPERIMENTAL
Intervention: Fadrozole hydrochloride 1.0 mg orally b.d.
Number of subjects: 80
Study 8595171 — intervention group
Group type: EXPERIMENTAL
Intervention: Fadrozole hydrochloride 2.0 mg orally b.d.
Number of subjects: 80
Study 2015175 — intervention group
Group type: EXPERIMENTAL
Intervention: Soluble ibuprofen 400 mg
Number of subjects: 0
Study 2015175 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen liquid in a gelatin capsule
Number of subjects: 0
Study 2015175 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen tablets (Nurofen)
Number of subjects: 0
Study 2015175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6799415 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor
Number of subjects: 68
Study 6799415 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V, Amoxicillin, Ampicillin, Erythromycin estolate, Erythromycin ethylsuccinate, Trimethoprim-sulfamethoxazole, Cefaclor
Number of subjects: 68
Study 31633369 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiences that provide a correlation between space and time
Number of subjects: 0
Study 31633369 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiences that provide a correlation between space and number
Number of subjects: 0
Study 29788075 — intervention group
Group type: EXPERIMENTAL
Intervention: PMT25341 (a mixture of synbiotics, omega-3/6 fatty acids and amino acids)
Number of subjects: 78
Study 29788075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 29133706 — intervention group
Group type: COMPARATOR
Intervention: Hypothermia
Number of subjects: 107
Study 29133706 — intervention group
Group type: COMPARATOR
Intervention: Progesterone
Number of subjects: 107
Study 29133706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 29133706 — intervention group
Group type: COMPARATOR
Intervention: Progesterone + Hypothermia
Number of subjects: 107
Study 25666004 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 μg of intravaginal misoprostol
Number of subjects: 88
Study 25666004 — intervention group
Group type: COMPARATOR
Intervention: 50 μg of intravaginal misoprostol
Number of subjects: 88
Study 25091932 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual Health Model (SHM) - two sessions of 3 hours of group education
Number of subjects: 84
Study 25091932 — intervention group
Group type: COMPARATOR
Intervention: PLISSIT model - total of 6 hours of one-on-one consultation at an interval of 1-2 weeks
Number of subjects: 84
Study 22441644 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 58
Study 22441644 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 19354344 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline plus counselling
Number of subjects: 0
Study 19354344 — intervention group
Group type: COMPARATOR
Intervention: Counselling alone
Number of subjects: 0
Study 19354344 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 0
Study 16780933 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 2817
Study 16780933 — intervention group
Group type: COMPARATOR
Intervention: Oral anticoagulant therapy (OAT)
Number of subjects: 2817
Study 16780933 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH
Number of subjects: 2817
Study 16780933 — intervention group
Group type: COMPARATOR
Intervention: OAT
Number of subjects: 2817
Study 16780933 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH and OAT
Number of subjects: 2817
Study 15219299 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized magnesium sulfate plus albuterol
Number of subjects: 0
Study 15219299 — intervention group
Group type: COMPARATOR
Intervention: Nebulized albuterol plus saline
Number of subjects: 0
Study 11463516 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 618
Study 11463516 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 618
Study 9879606 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 MU of lymphoblastoid IFN alpha 3 times a week for 12 months
Number of subjects: 504
Study 9879606 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 MU of lymphoblastoid IFN alpha 3 times a week for 24 months
Number of subjects: 504
Study 9879606 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 MU of lymphoblastoid IFN alpha 3 times a week for 12 months
Number of subjects: 504
Study 9879606 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 MU of lymphoblastoid IFN alpha 3 times a week for 24 months
Number of subjects: 504
Study 9879606 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily regimen of 3 MU for patients with unmodified AMT levels
Number of subjects: 504
Study 9879606 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 3 MU vs 6 MU
Number of subjects: 504
Study 9879606 — intervention group
Group type: COMPARATOR
Intervention: 24-month treatment vs 12-month treatment
Number of subjects: 504
Study 9879606 — intervention group
Group type: COMPARATOR
Intervention: Genotype analysis
Number of subjects: 504
Study 7743871 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross face transplantation of segmental latissimus dorsi muscle flap with super‐long neurovascular pedicle (one stage method)
Number of subjects: 21
Study 7743871 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross face nerve graft and secondary free muscle transplantation by neurovascular anastomoses (two stage method)
Number of subjects: 21
Study 7743871 — intervention group
Group type: EXPERIMENTAL
Intervention: Free muscle transplantation by microneurovascular anastomosis in paralyzed face
Number of subjects: 21
Study 7743871 — intervention group
Group type: COMPARATOR
Intervention: One stage method (compared to sural nerve graft with small saphenous vein anastomosis)
Number of subjects: 21
Study 2481532 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin III (AT III) concentrates
Number of subjects: 0
Study 2481532 — intervention group
Group type: COMPARATOR
Intervention: Heparin (additional administration)
Number of subjects: 0
Study 810198 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyrotrophin-releasing hormone (TRH) 600 mug, given daily for four days
Number of subjects: 20
Study 810198 — intervention group
Group type: COMPARATOR
Intervention: Placebo, given daily for four days
Number of subjects: 20
Study 31742629 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (n=57)
Number of subjects: 113
Study 31742629 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (n=56)
Number of subjects: 113
Study 28549430 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of reticulated hyaluronic acid (KARTILAGE® CROSS, 16 mg/ml, one single injection of 2.2 mL)
Number of subjects: 81
Study 28549430 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 81
Study 28549430 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular injection of reticulated hyaluronic acid (KARTILAGE® CROSS)
Number of subjects: 81
Study 25022226 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 13819
Study 25022226 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 13819
Study 25022226 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy (MT)
Number of subjects: 13819
Study 25022226 — intervention group
Group type: COMPARATOR
Intervention: Neurological events (NE) occurrence
Number of subjects: 13819
Study 23707085 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.2 μg/kg/h for 30 minutes before the procedure, followed by 0.4 μg/kg/h for 6 hours after the procedure)
Number of subjects: 50
Study 23707085 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 50
Study 23707085 — intervention group
Group type: COMPARATOR
Intervention: Control group (volume‐matched normal saline solution)
Number of subjects: 50
Study 23707085 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 21718523 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Internet-based cognitive-behavioral treatment for depression
Number of subjects: 12
Study 18941066 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine
Number of subjects: 47
Study 18941066 — intervention group
Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine
Number of subjects: 47
Study 15970035 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of garlic paste for 14 days
Number of subjects: 56
Study 15970035 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole solution
Number of subjects: 56
Study 12520172 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release tablets
Number of subjects: 20
Study 12520172 — intervention group
Group type: COMPARATOR
Intervention: Regular tablets
Number of subjects: 20
Study 10754455 — intervention group
Group type: EXPERIMENTAL
Intervention: VML 295 at 200 mg twice daily
Number of subjects: 36
Study 10754455 — intervention group
Group type: EXPERIMENTAL
Intervention: VML 295 at 200 mg once daily
Number of subjects: 36
Study 10754455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 8862229 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol (C) (25 mg)
Number of subjects: 15
Study 8862229 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 15
Study 8862229 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha- and beta-adrenergic blockade
Number of subjects: 15
Study 1636469 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation treatment program
Number of subjects: 459
Study 1636469 — intervention group
Group type: EXPERIMENTAL
Intervention: Restraint score
Number of subjects: 459
Study 6376404 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 750
Study 6376404 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamphenicol
Number of subjects: 750
Study 6376404 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin plus Thiamphenicol
Number of subjects: 750
Study 6376404 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 750
Study 30521781 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal mobilization with leg movement (SMWLM)
Number of subjects: 60
Study 30521781 — intervention group
Group type: COMPARATOR
Intervention: Exercise and electrotherapy
Number of subjects: 60
Study 28744938 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative body-mind-spirit (I-BMS) intervention
Number of subjects: 185
Study 28744938 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list (Control)
Number of subjects: 185
Study 26546385 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver dressing
Number of subjects: 43
Study 24925350 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori treatment with amoxicillin‐omeprazole
Number of subjects: 2258
Study 22924248 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine
Number of subjects: 60
Study 22924248 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 60
Study 20333738 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT/A treatment after diode laser hair removal
Number of subjects: 9
Study 20333738 — intervention group
Group type: COMPARATOR
Intervention: BoNT/A treatment without diode laser hair removal
Number of subjects: 9
Study 18303744 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean intermittent self‐catheterisation (CISC)
Number of subjects: 49
Study 18303744 — intervention group
Group type: COMPARATOR
Intervention: Urethral dilatation with sounds
Number of subjects: 49
Study 12682543 — intervention group
Group type: EXPERIMENTAL
Intervention: Diathermy hemorrhoidectomy
Number of subjects: 31
Study 12682543 — intervention group
Group type: COMPARATOR
Intervention: Stapled hemorrhoidectomy
Number of subjects: 31
Study 10860190 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibition (Ramipril)
Number of subjects: 4937
Study 10860190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4937
Study 9114632 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers of patients with cancer-related pain
Number of subjects: 128
Study 9114632 — intervention group
Group type: COMPARATOR
Intervention: Caregivers of pain-free patients
Number of subjects: 128
Study 8470417 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (1.2 mg sublingually)
Number of subjects: 40
Study 8470417 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (10 mg capsule, chewed and swallowed)
Number of subjects: 40
Study 2949080 — intervention group
Group type: EXPERIMENTAL
Intervention: Mode of presenting reinforcement (part of the sign-requested reinforcement)
Number of subjects: 3
Study 2949080 — intervention group
Group type: EXPERIMENTAL
Intervention: Least-to-most prompting procedure
Number of subjects: 3
Study 2949080 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal of the least-to-most prompting procedure
Number of subjects: 3
Study 29486502 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Capsule Endoscopy (VCE)
Number of subjects: 756
Study 29486502 — intervention group
Group type: COMPARATOR
Intervention: Computed Tomography Colonography (CTC)
Number of subjects: 756
Study 26700123 — intervention group
Group type: EXPERIMENTAL
Intervention: PRE-ACT
Number of subjects: 1255
Study 26700123 — intervention group
Group type: COMPARATOR
Intervention: Control (NCI text)
Number of subjects: 1255
Study 26700123 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PRE-ACT and Control
Number of subjects: 1255
Study 24468006 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloid cardioplegia (Group 1)
Number of subjects: 100
Study 24468006 — intervention group
Group type: COMPARATOR
Intervention: Blood cardioplegia (Group 2)
Number of subjects: 100
Study 22098442 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried and crushed sea buckthorn berries
Number of subjects: 0
Study 22098442 — intervention group
Group type: EXPERIMENTAL
Intervention: Sea buckthorn CO₂ extraction residue (CO₂-sea buckthorn)
Number of subjects: 0
Study 22098442 — intervention group
Group type: EXPERIMENTAL
Intervention: Sea buckthorn CO₂ and ethanol extraction residue (CO₂-EtOH-sea buckthorn)
Number of subjects: 0
Study 22098442 — intervention group
Group type: EXPERIMENTAL
Intervention: Black currant CO₂ and ethanol extraction residue (CO₂-EtOH-black currant)
Number of subjects: 0
Study 22098442 — intervention group
Group type: COMPARATOR
Intervention: Control (berry-depleted meals)
Number of subjects: 0
Study 20117244 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous therapy with certolizumab pegol (400 mg every 4 weeks)
Number of subjects: 0
Study 20117244 — intervention group
Group type: COMPARATOR
Intervention: Drug-interruption (placebo)
Number of subjects: 0
Study 18825548 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine use in the past 30 days
Number of subjects: 4605
Study 18825548 — intervention group
Group type: EXPERIMENTAL
Intervention: Methamphetamine use in the past 12 months
Number of subjects: 4605
Study 15912558 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 254
Study 15912558 — intervention group
Group type: COMPARATOR
Intervention: Citalopram
Number of subjects: 254
Study 15912558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 12734161 — intervention group
Group type: EXPERIMENTAL
Intervention: Belscope (BP)
Number of subjects: 500
Study 12734161 — intervention group
Group type: EXPERIMENTAL
Intervention: Miller (MIL)
Number of subjects: 500
Study 12734161 — intervention group
Group type: EXPERIMENTAL
Intervention: McCoy (MC)
Number of subjects: 500
Study 12734161 — intervention group
Group type: EXPERIMENTAL
Intervention: Macintosh (M)
Number of subjects: 500
Study 12734161 — intervention group
Group type: EXPERIMENTAL
Intervention: Lee-Fiberview (LF)
Number of subjects: 500